Late-life depression (LLD) with high prevalence accelerates cognitive impairment and becomes a risk factor for dementia, yet the pathogenesis of LLD is still…
Molecular Basis Underlying Changes of Brain Entropy and Couplings in Late-life Depression.
Late-life depression (LLD) with high prevalence accelerates cognitive impairment and becomes a risk factor for dementia, yet the pathogenesis of LLD is still…
Here’s what psychedelics actually do to the brain – AOL.com
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PsychedelicsNeuropharmacologyMental HealthClinical TrialsPatient Counseling Why This MattersPsychedelics are entering mainstream medical practice through FDA...
Nose-to-Brain Delivery System for Incorporating Monoterpenes with Anti-Depressant Potential.
Depression is a prevalent and disabling disease influenced by genetic, immunological, and environmental factors. Although conventional treatments are effecti…
Cannabidiol reduces the latency for the behavioral effect of escitalopram in chronically stressed male mice: involvement of NAPE-PLD expressed in parvalbumin-positive interneurons and the prefrontal cortex.
Antidepressant drugs are the first-line treatment for chronic stress-related psychiatric disorders such as major depressive disorder, anxiety disorders, and …